PP
AUPH icon

Patten & Patten’s Aurinia Pharmaceuticals AUPH Stock Holding History

Patten & Patten’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$748K Sell
50,500
-12,500
-20% -$183K 0.05% 209
2025
Q4 		$1M Sell
63,000
-6,625
-10% -$93.9K 0.06% 185
2025
Q3 		$769K Sell
69,625
-2,961
-4% -$32.3K 0.05% 213
2025
Q2 		$615K Hold
72,586
– – 0.04% 211
2025
Q1 		$584K Sell
72,586
-2,768
-4% -$22.4K 0.04% 211
2024
Q4 		$677K Sell
75,354
-17,190
-19% -$140K 0.04% 199
2024
Q3 		$678K Hold
92,544
– – 0.05% 196
2024
Q2 		$528K Buy
92,544
+15,429
+20% +$81.3K 0.04% 211
2024
Q1 		$386K Buy
+77,115
New +$523K 0.03% 235

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return